UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021069
Receipt number R000024306
Scientific Title Placebo-controlled double-blinded parallel randomized study to test the urate-lowering effect of yogurt containing Lactobacillus gasseri PA-3 in adult males with marginal hyperuricemia
Date of disclosure of the study information 2016/02/17
Last modified on 2016/02/17 14:25:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Placebo-controlled double-blinded parallel randomized study to test the urate-lowering effect of yogurt containing Lactobacillus gasseri PA-3 in adult males with marginal hyperuricemia

Acronym

A study on the effect of the yogurt containing Lactobacillus gasseri PA-3 on uric acid level.

Scientific Title

Placebo-controlled double-blinded parallel randomized study to test the urate-lowering effect of yogurt containing Lactobacillus gasseri PA-3 in adult males with marginal hyperuricemia

Scientific Title:Acronym

A study on the effect of the yogurt containing Lactobacillus gasseri PA-3 on uric acid level.

Region

Japan


Condition

Condition

Healthy male adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of the Lactobacillus gasseri PA-3 on uric acid level.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Serum uric acid level

Key secondary outcomes

Urine uric acid level


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

A 85g Yogurt non-containing Luctobacillus gasseri PA-3 is give for 8 weeks

Interventions/Control_2

A 85g Yogurt low-concentration Luctobacillus gasseri PA-3 give for 8 weeks

Interventions/Control_3

A 85g Yogurt hight-concentration Luctobacillus gasseri PA-3 give for 8 weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1.Who gave the informed consents in writing after receiving enough explanation of the purpose and detail of the study, understanding the study well, and deciding to attend the study with their own will.
2.Subjects who meets the following condition at the time of a check before absorption.
1)35years of age or older male
2)Serum uric acid level are 6.0mg/dL over.

Key exclusion criteria

1.Subjects with Phamacotherapy,Exercise therapy and Medical diet of hyperuricemia(gout).
2.Subjects with a history of gout or hyperuricemia.
3.Subjects with a using healthy food about hyperuricemia commonly.
4.Subjects who are judged ineligible by the principal investigator or subinvestigator.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Minoru Sekine

Organization

Tsukuba International Clinical Pharmacology Clinic

Division name

Clinicall Management Department

Zip code


Address

1-21-16 kannondai,tsukuba city,Ibarakii 305-0856,Japan

TEL

029-839-1150

Email

m-sekine@tsukuba-icp.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masaaki Mochii

Organization

Tsukuba International Clinical Pharmacology Clinic

Division name

Clinicall Management Department

Zip code


Address

1-21-16 kannondai,tsukuba city,Ibarakii 305-0856,Japan

TEL

029-839-1150

Homepage URL


Email

m-mochii@tsukuba-icp.jp


Sponsor or person

Institute

Tsukuba International Clinical Pharmacology Clinic

Institute

Department

Personal name



Funding Source

Organization

Meiji Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

つくば国際臨床薬理クリニック(茨城県)


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The results of the analysis after excluding the data with purine intake of over 450 mg/day have shown that serum urate of the high-concentration group was significantly lower than the placebo group at week 2 (P = 0.025), and the linear regression analysis has indicated a dose-dependent decrease of serum urate ( P = 0.046). The equivalent analysis using the data at week 8 also showed that serum urate of the high-concentration group was significantly lower than the placebo group (P = 0.031), and the linear regression analysis indicated a dose-dependent decrease of serum urate ( P = 0.021). Those data suggest that yogurt containing L. gasseri PA-3 lower serum urate.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 12 Month 19 Day

Date of IRB


Anticipated trial start date

2013 Year 01 Month 28 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete

2013 Year 06 Month 20 Day

Date analysis concluded

2013 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 02 Month 17 Day

Last modified on

2016 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024306


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name